The Effect of Salutogenic Model-Based Care on Mothers of Children Suffering From Febrile Illness

December 4, 2025 updated by: Ayça Demir Yıldırım, PhD, Istanbul University - Cerrahpasa
This study was designed as an experimental study with pre-test-post-test comparisons and control groups, in order to investigate the effects of salutogenic model-based care on the individual integrity and coping attitudes of mothers with febrile children.

Study Overview

Status

Completed

Conditions

Detailed Description

The research was conducted with 90 mothers, 45 in the experimental group and 45 in the control group, with children aged 0-5 years who were diagnosed with fever and admitted to the pediatric emergency department of Zeynep Kâmil Women and Children's Diseases Education and Research Hospital between October 1, 2023 and May 1, 2024. A total of three data collection forms were used in the research: Personal Introduction Form, Individual Integrity Sense Scale, and Coping Attitudes Assessment Scale. While the salutogenic care model was applied to the mothers in the experimental group (n=45), the routine midwifery care applied in the department was given to the mothers in the control group (n=45).

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Üsküdar
      • Istanbul, Üsküdar, Turkey (Türkiye), 34672
        • Uskudar University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The child must have applied to the emergency room with a fever complaint
  • Have at least a primary school level education

Exclusion Criteria:

  • The child with a fever must be over 5 years old
  • Having a psychological disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
While applying the salutogenic care model to the mothers in the experimental group (n=45), a total of three data collection forms were used: the Personal Introduction Form, the Sense of Individual Integrity Scale, and the Coping Attitudes Assessment Scale.

Salutogenic Care Model Training Program This is a training program that involves meeting with the salutogenic care model in 3 sessions, providing both fever-related training and completing forms.

  1. st Interview: Comprehensibility phase; This includes providing the mother with information about fever, ensuring that she is informed about fever, the cause of fever and what she should do.
  2. nd Interview: Management phase; This includes ensuring that the mother knows which practices are effective in cases of fever, the amount, timing and frequency of medication administration, and the complications that may develop if the fever is not treated correctly.
  3. rd Interview: Meaningfulness phase; This includes ensuring that the mother does not panic during a fever, preventing her fears, and reducing her anxiety because she knows how to approach a feverish child.
No Intervention: Control Group
While routine midwifery care was given to mothers in the control group (n=45) in the service, a total of three data collection forms were used: a Personal Introduction Form, the Sense of Individual Integrity Scale, and the Coping Attitudes Assessment Scale.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
COPE-Coping Attitudes Assessment Scale
Time Frame: 6 months
COPE-Coping Attitudes Assessment Scale "Ways of Coping" was developed by Folkman and Lazarus in 1980 and COPE was developed by Carver, Scheier and Weintraub in 1989 (Folkman et al. 1980, Wegner et al. 1987). Coping Attitudes Assessment Scale is a self-report scale consisting of 60 questions and 15 subscales. Questions are answered with the options "I never do it" (1), "I occasionally do it" (2), "I do it moderately" (3), "I do it often" (4). Each of the subscales provides information about a different coping attitude. The higher the score a person gets from the subscales provides information about which coping attitude the person uses more.
6 months
Outcome Measure
Time Frame: 6 months

The Sense of Integrity Scale The Sense of Integrity Scale used in the study was developed by Antonovsky (1987) to measure the abilities of individuals to maintain their health despite stress. The first version of the SOC consists of 29 items on a 7-point Likert-type scale. Eleven items on this scale relate to "understandability," eight items to "meaningfulness," and ten items to "manageability" (Geyer 1997).

In 1987, Antonovsky revised the existing SOC scale and developed a shorter version consisting of 13 items. In this short version, five items measure understandability, four items to "meaningfulness," and the remaining four items to "manageability," all on a 7-point Likert-type scale. The scale is a self-report scale consisting of 13 items ranging from 1 to 7. It varies between 13 and 91 points.

6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ayça Demir Yıldırım, PhD, Uskudar University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2023

Primary Completion (Actual)

May 1, 2024

Study Completion (Actual)

January 30, 2025

Study Registration Dates

First Submitted

November 24, 2025

First Submitted That Met QC Criteria

November 24, 2025

First Posted (Estimated)

December 4, 2025

Study Record Updates

Last Update Posted (Actual)

December 11, 2025

Last Update Submitted That Met QC Criteria

December 4, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Ü.Ü. Ebe Aslıhan BAŞ

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

A research article is planned to make the individual participant data (IPD) available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mothers

Clinical Trials on Salutogenic Care Model Training Program

Subscribe